Short answer
Cardinal Health (CAH) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Fiscal-year and quarterly results released for periods ended June 30, 2026.
Cardinal Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal-year and quarterly results released for periods ended June 30, 2026
- Exhibit 99.1 contains Cardinal Health’s earnings figures and management commentary
Item 7.01 · Regulation FD Disclosure
- Management webcast scheduled for August 11, 2026 at 8:30 a.m. Eastern
- Discussion covers quarter and fiscal year ended June 30, 2026
- Fiscal 2027 outlook provides potentially material forward guidance
- Slides and audio replay available through Cardinal Health’s investor-relations website
Item EX-99.1 · Exhibit EX-99.1
- Q4 revenue rose 6% to $63.7B, while non-GAAP EPS increased 40% to $2.91
- Underlying Q4 non-GAAP EPS rose 25% to $2.60 excluding the $0.31 IEEPA tariff refund benefit
- FY2026 adjusted free cash flow reached $5.0B, supporting $1.4B of repurchases and a new $5.0B authorization
- FY2027 non-GAAP EPS guidance of $12.40–$12.60 implies 13%–15% growth above long-term guidance
- Pharmaceutical profit increased 23% to $2.8B, while Other segment profit grew 37% to $707M in FY2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardinal Health 8-K filings
Get the next CAH 8-K as it lands
Follow CAH for push alerts, or ask the research agent what this filing means.